- Dosage: Iodine 300mg/ mL
- Volume: 100 ml bottle
- Packaging: 100 ml bottle*60 carton
- Shelf Life: 36 months
Package:
Product Description
Iopamidol Injection 300mgI/mL 100ml: What the Published Guidance Says
Infection-prevention consumables and single-use medical devices supplied alongside our pharmaceutical range, so a programme can source the medicine and the means to deliver it safely from one supplier.
Iopamidol Injection 300mgI/mL 100ml sits in the Devices & Antisepsis range. The notes below are the ones that most often change a specification, a label or a tender submission.
- Diagnostic contrast media are listed medicines The Model List includes diagnostic medicines such as barium sulfate and meglumine iotroxate — a reminder that contrast agents, including our iopamidol injection, sit inside the medicines regulatory framework rather than the device framework. WHO Model List of Essential Medicines, 24th List (2025) — report of the 25th WHO Expert Committee (TRS 1064)
- MSF's handling rules for cord-care chlorhexidine MSF specifies the 7.1% gel for the umbilical cord only, states it must not be used on other parts of the body, warns against combining it with soap or other antiseptics such as povidone-iodine because of incompatibility, and notes the 3 g single-dose presentation is preferred over the 20 g tube to reduce contamination from opened tubes. MSF Essential Drugs — Chlorhexidine 7.1% dermal gel
- Chlorhexidine is an EML antiseptic, and its concentration matters Section 15.1 of the 24th WHO Model List (2025) carries chlorhexidine solution 5% (digluconate) among antiseptics, alongside ethanol 70% and povidone iodine. For newborn cord care, section 22.7 lists a different specification entirely: chlorhexidine 7.1% digluconate delivering 4% chlorhexidine. These are not interchangeable products. WHO Model List of Essential Medicines, 24th List (2025) — report of the 25th WHO Expert Committee (TRS 1064)
We quote these sources rather than paraphrase them loosely, because the detail matters commercially for Iopamidol Injection 300mgI/mL 100ml. Where your national list differs from the WHO listing, the national list governs what may be supplied and promoted locally.
Iopamidol Injection 300mgI/mL 100ml — Supply Parameters
| Therapeutic group | Devices & Antisepsis — Devices & Antisepsis |
| Manufacturer | Sinophare Bio-technology Co., Ltd. (GMP, China) |
| Documentation supplied | COA, HPLC/GC data, stability data, dossier package |
The same therapeutic range is supplied in several presentations, so one purchase order can cover a mixed requirement: Continuous Glucose Monitoring System (CGMS), Disposable Syringe Medical Sterile Plastic Syringe with Needle, Disposable 100ml Infusion Set With Burette For Children Tape-A Sterile IV Drip Set, Disposable Infusion IV Sets Sterile Medical Intravenous Drip Set, Medical Adhesive Tape Disposable Surgical Micropore Breathable Tape, Disposable Medical Mask, Disposable Fetal Head Suction Device Vacuum Obstetric Delivery Cup, Disposable Nitrile Gloves Powder Free Latex Free Medical Exam Gloves.
Quality Control, Pharmacopoeial Standards & Documentation
Products are manufactured and tested against USP, EP, BP and CP monographs, with incoming raw-material inspection, in-process monitoring and full finished-product testing.
Every batch of Iopamidol Injection 300mgI/mL 100ml is tested to the monograph stated on the purchase order. Where a monograph is silent on the presentation, we agree a written specification with you in advance and reference it on the certificate of analysis.
Standardised GMP production workshops with an independent R&D laboratory and a complete quality-inspection centre.
A typical release panel for this presentation covers:
- Testing for heavy metals and elemental impurities
- Testing for packaging integrity and seal testing
- Testing for description and identification
- Testing for assay of the active substance
- Testing for related substances and impurities
- Testing for dissolution or release profile (solid oral forms)
COA, HPLC and GC data, DMF and dossier packages, plus registration support documents for national marketing-authorisation filings.
Packaging, Labelling & Export
- Pack size: 100 ml bottle*60 carton. Non-standard pack sizes can be quoted against your artwork.
- Shelf life: 36 months. Stability data for the marketed pack is included in the dossier.
- Labelling: artwork can be produced in English, Arabic, French, Russian and Spanish, with your own brand and language mix, subject to the labelling rules of the destination market.
- Export: GMP certificate, COA, certificate of origin, packing list and, where required, the free-sale or marketing authorisation certificate from the country of manufacture.
Registration, Dossier & Tender Support
Documents for Iopamidol Injection 300mgI/mL 100ml are issued by Sinophare Bio-technology Co., Ltd. — DML Number Jin20160068 (medicines) and Jin20160069 (paracetamol API).. Keeping one legal manufacturer across the COA, the GMP certificate and the registration file avoids assessment queries later.
- CTD dossier modules 1–5 in editable and PDF form, with the finished-product and API sections cross-referenced.
- Site Master File and GMP certificate for the manufacturing workshops.
- Method validation, stability protocol and the shelf-life justification for the marketed pack.
- Answers to authority questions during assessment, handled by the regulatory contact who prepared the file.
- Tender and framework documentation, including pre-qualification questionnaires and sample logistics.
The context for Iopamidol Injection 300mgI/mL 100ml is its place among antiseptics and medical consumables referenced in WHO guidance. Listing status informs how programmes specify a product; it is not a substitute for the import licence or marketing authorisation of the destination country.
Frequently Asked Questions
What pack size is available for Iopamidol Injection 300mgI/mL 100ml?
This presentation is normally supplied as 100 ml bottle*60 carton. Where your market requires a different count, bottle or carton, we quote to your artwork and extend the stability file to the new pack.
What documentation comes with a shipment of Iopamidol Injection 300mgI/mL 100ml?
Shipments are accompanied by a certificate of analysis covering identification, assay and related substances, together with the marketed-pack stability data and the manufacturing site GMP certificate. Shelf life: 36 months.
Does the batch documentation for Iopamidol Injection 300mgI/mL 100ml support a registration filing?
Shipments are accompanied by a certificate of analysis covering identification, assay and related substances, together with the marketed-pack stability data and the manufacturing site GMP certificate. Shelf life: 36 months. The full CTD dossier and the authority assessment file are supplied as part of a registration order; routine shipments carry the COA and stability data only.
What chlorhexidine specifications do you supply?
Both the 2% chlorhexidine gluconate solution used as a general antiseptic and the 7.1% digluconate cord-care gel delivering 4% chlorhexidine specified in section 22.7 of the Model List. These are different products for different indications.
Why do you highlight the WHO chlorhexidine alert?
Because container confusion between chlorhexidine and eye preparations has caused more than 40 cases of serious eye injury including blindness. Selecting a visually distinct container is a WHO recommendation and we treat it as a specification, not an afterthought.
Related Devices & Antisepsis Products
- Continuous Glucose Monitoring System (CGMS)
- Disposable Syringe Medical Sterile Plastic Syringe with Needle
- Disposable 100ml Infusion Set With Burette For Children Tape-A Sterile IV Drip Set — 100ml
- Disposable Infusion IV Sets Sterile Medical Intravenous Drip Set
- Medical Adhesive Tape Disposable Surgical Micropore Breathable Tape
- Disposable Medical Mask
Browse the full Devices & Antisepsis range; all Injectables; the complete product catalogue.
Request a Quotation for Iopamidol Injection 300mgI/mL 100ml
For tenders and programme supply, send the line item, pack size, quantity and destination for Iopamidol Injection 300mgI/mL 100ml 100ml. We return a quotation with lead time, documentation list and sample availability in one response.
Sources & Regulatory Notes
- WHO Model List of Essential Medicines, 24th List (2025) — report of the 25th WHO Expert Committee (TRS 1064)
- MSF Essential Drugs — Chlorhexidine 7.1% dermal gel
Reference information only. The published guidance summarised on this page is quoted for professional and regulatory-context purposes and does not constitute medical advice, a prescribing recommendation or a promotion of any product for a particular indication. Prescribing decisions must follow the approved product information and national treatment guidelines in the market of use.
